KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 36 days ( 4.81 % )
Last Price $0.0428 0 %
High/ Low $0.0428 - $0.0428 0%
Chg 7 Days N/A $0.0428 $0.0428
Chg 30 Days N/A $0.0428 $0.0428
Chg 12 mos -54.14 % $0.0934 $0.0428
Trend - 3 mos -7.75 % Width: 39.17 %
Trend - 12 mos -55.95 % Width: 371.42 %
Pred. range - 3 mos $0.0312 - $0.0434 -27.25 % - 1.25 %
Pred. range - 12 mos N/A - $0.0376 -100.00 % - -12.32 %
Short MA avg 3 mos Buy Mar 19, 2024 - 28 days
Long MA avg 3 mos Buy Apr 16, 2024 - 9 days
Short/Long MA avg 3 mos Buy Apr 16, 2024 - 9 days
Short MA avg 12 mos Buy Apr 09, 2024 - 14 days
Long MA avg 12 mos Sell Aug 17, 2023 - 175 days
Short/Long MA avg 12 mos Sell Aug 24, 2023 - 170 days
Pivot Short Buy Apr 25, 2024 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Replicel Life Science Ord

Replicel Life Science Ord RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy, which isolates an individual's own cells from harvested tissues and growing more in controlled conditions in a laboratory. The company's product candidates include RCT-01 for the treatment of chronic tendinosis; RCS-01 to treat aging and sun damaged skin;... REPCF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT